Combined Transplant-Vaccine Therapy For High-risk Leukemia Shows Promise, Dana-Farber Cancer Institute Study

Dana-Farber Cancer Institute -- Two of the most powerful approaches to cancer treatment — a stem cell transplant and an immune system-stimulating vaccine — appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.

MORE ON THIS TOPIC